YaSheng Group
HERB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.07 | -0.09 | 0.15 |
| FCF Yield | -3.71% | 3.95% | -12.08% | 3.18% |
| EV / EBITDA | 4.88 | 15.23 | 12.40 | 8.50 |
| Quality | ||||
| ROIC | 0.68% | 0.46% | 0.32% | 0.66% |
| Gross Margin | 33.74% | 33.90% | 22.71% | 33.36% |
| Cash Conversion Ratio | 0.20 | 1.17 | -0.28 | 0.33 |
| Growth | ||||
| Revenue 3-Year CAGR | -65.76% | -70.05% | -72.95% | -74.30% |
| Free Cash Flow Growth | -149.10% | 149.12% | -401.63% | -27.31% |
| Safety | ||||
| Net Debt / EBITDA | -1.31 | -1.71 | -2.25 | -2.26 |
| Interest Coverage | 1,343.31 | 787.88 | 814.35 | 2,408.97 |
| Efficiency | ||||
| Inventory Turnover | 4.11 | 2.72 | 1.71 | 2.40 |
| Cash Conversion Cycle | 34.11 | 46.69 | 56.84 | 42.47 |